Author Response: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study

Neurology. 2021 May 4;96(18):870. doi: 10.1212/WNL.0000000000011868.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Humans
  • Multiple Sclerosis* / drug therapy
  • Multiple Sclerosis, Relapsing-Remitting*
  • Vaccines*

Substances

  • Antibodies, Monoclonal, Humanized
  • Vaccines
  • ocrelizumab